SCHEMBL20361981

SCHEMBL20361981

CCOC(=O)c1nc(-c2ccccc2)oc1-c1ccccc1[N+](=O)[O-]

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TARBP2 Q15633 7/20 0.58
ALDH1A1 P00352 6/20 0.56
KDM4E B2RXH2 3/20 0.56
HSD17B10 Q99714 3/20 0.56
HPGD P15428 2/20 0.56
KMT2A Q03164 1/20 0.56
PDCD4 Q53EL6 1/20 0.46
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
MAPT P10636 2/20 0.42
PKM P14618 1/20 0.42
ALOX15 P16050 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
SLC5A1 P13866 1/20 0.41
SLC5A2 P31639 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29158993 0.98 TARBP2 (0.61) TARBP2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL29158785 0.93 TARBP2 (0.52) TARBP2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL21541935 0.92 TARBP2 (0.59) TARBP2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL30740865 0.92 TARBP2 (0.59) TARBP2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL29158670 0.92 TARBP2 (0.51) TARBP2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL21541932 0.91 TARBP2 (0.60) TARBP2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL30740866 0.91 TARBP2 (0.60) TARBP2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL29158733 0.90 KDM4E (0.53) TARBP2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL30106264 0.90 TARBP2 (0.49) TARBP2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL29158571 0.90 TARBP2 (0.49) TARBP2ALDH1A1KDM4EHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11168094-B2 Quinolinone derivative and pharmaceutical composition for preventing or treating allergic diseases such as asthma or atopic dermatitis including the quinolinone derivative as active ingredient AZCURIS CO., LTD. (KR) 2021-11-09 US disclosed
US-20200140457-A1 NOVEL QUINOLINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES SUCH AS ASTHMA OR ATOPIC DERMATITIS INCLUDING THE QUINOLINONE DERIVATIVE AS ACTIVE INGREDIENT KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG CAMPUS (KR) 2020-05-07 US disclosed
EP-3567044-A1 NOVEL QUINOLINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASE SUCH AS ASTHMA OR ATOPY COMPRISING SAME AS ACTIVE INGREDIENT Korea University Research and Business Foundation, Sejong Campus (KR) 2019-11-13 EP disclosed
WO-2018128407-A1 NOVEL QUINOLINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASE SUCH AS ASTHMA OR ATOPY COMPRISING SAME AS ACTIVE INGREDIENT 고려대학교 세종산학협력단 2018-07-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11168094-B2 Quinolinone derivative and pharmaceutical composition for preventing or treating allergic diseases such as asthma or atopic dermatitis including the quinolinone derivative as active ingredient TSLP, IL33, IL5 TARBP2 3669/4885ALDH1A1 1899/4885KDM4E 3092/4885
US-20200140457-A1 NOVEL QUINOLINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES SUCH AS ASTHMA OR ATOPIC DERMATITIS INCLUDING THE QUINOLINONE DERIVATIVE AS ACTIVE INGREDIENT TSLP, IL33, TMEM33 TARBP2 3633/4885ALDH1A1 1038/4885KDM4E 3166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.